Hims & Hers Health (HIMS) News Today → Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad) Free HIMS Stock Alerts $17.55 -1.05 (-5.65%) (As of 05/21/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 21 at 6:51 PM | marketbeat.comHims & Hers Health, Inc. (NYSE:HIMS) Insider Soleil Boughton Sells 4,915 SharesHims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) insider Soleil Boughton sold 4,915 shares of the business's stock in a transaction on Monday, May 20th. The shares were sold at an average price of $20.01, for a total value of $98,349.15. Following the completion of the sale, the insider now owns 159,357 shares of the company's stock, valued at $3,188,733.57. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.May 21 at 2:59 PM | msn.comHims & Hers is selling an Ozempic knockoff without FDA approval. Here's howMay 21 at 2:20 PM | marketbeat.comHims & Hers Health (NYSE:HIMS) Sees Large Volume IncreaseHims & Hers Health (NYSE:HIMS) Sees Large Volume IncreaseMay 21 at 9:58 AM | msn.comHims & Hers Health says it will offer compounded GLP-1 injectionsMay 21 at 8:52 AM | marketbeat.comMckinley Capital Management LLC Purchases 231,867 Shares of Hims & Hers Health, Inc. (NYSE:HIMS)Mckinley Capital Management LLC boosted its stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 34.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 896,020 shares of the company's stock aftMay 21 at 8:15 AM | seekingalpha.comHims & Hers: Soaring On Access To Compounded GLP-1 Drugs, Further Volatility AheadMay 21 at 5:12 AM | americanbankingnews.comHims & Hers Health, Inc. (NYSE:HIMS) Insider Irene Becklund Sells 943 Shares of StockMay 21 at 5:11 AM | insidertrades.comHims & Hers Health, Inc. (NYSE:HIMS) Insider Irene Becklund Sells 943 SharesMay 20 at 10:35 PM | msn.comWellness Platform Hims & Hers Health Adds GLP-1 Injections For Weight Loss, Stock SoarsMay 20 at 10:35 PM | msn.comHims & Hers Stock Hits 3-Year High After Announcing $199 Weight-Loss Alternative To WegovyMay 20 at 10:35 PM | msn.comHims & Hers’ surprise 85% Wegovy discount is latest step on a journey to make medicine less ‘paternalistic,’ exec saysMay 20 at 7:26 PM | marketbeat.comInsider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells 943 Shares of StockHims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) insider Irene Becklund sold 943 shares of the stock in a transaction that occurred on Friday, May 17th. The stock was sold at an average price of $14.50, for a total value of $13,673.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.May 20 at 5:34 PM | msn.comTop Stock Movers Now: Jabil, Norwegian Cruise Line, Hims & Hers Health, and MoreMay 20 at 5:34 PM | msn.comHims & Hers surges on cheap compounded versions of Novo Nordisk's semaglutideMay 20 at 5:34 PM | markets.businessinsider.comHims & Hers Health’s Strategic Growth in Weight Loss Market Warrants Buy Rating Despite Regulatory RisksMay 20 at 5:34 PM | msn.comHims & Hers Stock Spikes. It’s Taking on Big Pharma With Cheap Obesity Shots.May 20 at 5:15 PM | investopedia.comHims & Hers Health Stock Jumps Nearly 28% on Plans to Offer GLP-1 Weight-Loss DrugsMay 20 at 3:16 PM | investorplace.comHIMS Stock Alert: Hims & Hers Shares Rocket on Weight Loss InjectionsMay 20 at 12:58 PM | marketbeat.comHims & Hers Health, Inc. (NYSE:HIMS) Shares Sold by Hillsdale Investment Management Inc.Hillsdale Investment Management Inc. trimmed its stake in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 33.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 283,650 shares of the company's stock aftMay 20 at 12:51 PM | marketbeat.comHims & Hers Health (NYSE:HIMS) Shares Gap Up to $14.57Hims & Hers Health (NYSE:HIMS) Shares Gap Up to $14.57May 20 at 12:34 PM | stockhouse.comHims & Hers Announces Access to GLP-1 Injections, Passing Cost Savings Onto CustomersMay 20 at 12:34 PM | benzinga.comHims & Hers Health Options Trading: A Deep Dive into Market SentimentMay 20 at 12:34 PM | finance.yahoo.comWeight loss: Hims & Hers introduce access to GLP-1 injectionsMay 20 at 12:34 PM | wsj.comHeard on the Street: Hims Is Jumping on a Crowded Ozempic BandwagonMay 20 at 12:34 PM | detroitnews.comHims debuts $199 weight-loss shots at 85% discount to WegovyMay 20 at 12:34 PM | marketwatch.comHims & Hers Health says it will offer compounded GLP-1 drugs, despite FDA warningsMay 20 at 12:23 PM | proactiveinvestors.comHims & Hers rallies after announcing access to GLP-1 injectionsMay 20 at 9:00 AM | cnbc.comHims & Hers Health adds compounded GLP-1 injections to weight loss programMay 20 at 8:33 AM | investorplace.comStock Market Mayhem: 3 Companies Ready to Shake Things UpMay 18 at 6:00 PM | marketbeat.comForerunner Ventures Management LLC Takes $86.84 Million Position in Hims & Hers Health, Inc. (NYSE:HIMS)Forerunner Ventures Management LLC purchased a new stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 9,756,893May 17, 2024 | marketbeat.comBaader Bank Aktiengesellschaft Trims Stake in Hims & Hers Health, Inc. (NYSE:HIMS)Baader Bank Aktiengesellschaft trimmed its position in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 38.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 171,286 shares of the company's stock after selling 109,014 sharMay 17, 2024 | americanbankingnews.comHims & Hers Health, Inc. (NYSE:HIMS) Short Interest UpdateMay 17, 2024 | americanbankingnews.comContrasting Auna (NYSE:AUNA) & Hims & Hers Health (NYSE:HIMS)May 16, 2024 | businesswire.comHims & Hers Welcomes Anja Manuel, Foreign Policy Expert, Domestic Regulations Advisor, and Former Diplomat to its Board of DirectorsMay 15, 2024 | insidertrades.comSoleil Boughton Sells 2,503 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) StockMay 14, 2024 | marketbeat.comHims & Hers Health, Inc. (NYSE:HIMS) Insider Soleil Boughton Sells 2,503 SharesHims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) insider Soleil Boughton sold 2,503 shares of Hims & Hers Health stock in a transaction on Monday, May 13th. The stock was sold at an average price of $12.33, for a total transaction of $30,861.99. Following the sale, the insider now directly owns 159,357 shares in the company, valued at approximately $1,964,871.81. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.May 14, 2024 | americanbankingnews.comHims & Hers Health, Inc. (NYSE:HIMS) Insider Patrick Harrison Carroll Sells 10,000 SharesMay 14, 2024 | insidertrades.comInsider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells 10,000 Shares of StockMay 13, 2024 | finance.yahoo.comInsider Sale: Chief Medical Officer of Hims & Hers Health Inc (HIMS) Sells SharesMay 13, 2024 | marketbeat.comHims & Hers Health, Inc. (NYSE:HIMS) Insider Sells $130,000.00 in StockHims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) insider Patrick Harrison Carroll sold 10,000 shares of the business's stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $13.00, for a total transaction of $130,000.00. Following the sale, the insider now directly owns 173,880 shares in the company, valued at approximately $2,260,440. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.May 13, 2024 | marketbeat.com3 Stocks That Suddenly Drew in Options TradersOptions are complicated and not for the faint of heart. While some investors may use them to take on irresponsible leverage levels on their minor positions, others could use them to express their predictions on a particular stock.May 13, 2024 | marketbeat.com3 Stocks That Suddenly Drew in Options Traders (HIMS)Three discounted stocks caught the attention of call option buyers last week, and they have Wall Street analysts to back them through double-digit upside.May 13, 2024 | fool.comIs Hims & Hers Health Stock a Buy?May 11, 2024 | americanbankingnews.comBrokers Offer Predictions for Hims & Hers Health, Inc.'s Q4 2024 Earnings (NYSE:HIMS)May 11, 2024 | fool.comHims & Hers Health Shares Climb After News of Double-Digit Revenue Growth. Is It Too Late to Buy the Stock?May 10, 2024 | marketbeat.comHims & Hers Health, Inc. (NYSE:HIMS) Forecasted to Earn Q4 2024 Earnings of $0.03 Per ShareHims & Hers Health, Inc. (NYSE:HIMS - Free Report) - Equities researchers at Leerink Partnrs cut their Q4 2024 earnings estimates for Hims & Hers Health in a research note issued to investors on Tuesday, May 7th. Leerink Partnrs analyst M. Cherny now expects that the company will post earnings ofMay 9, 2024 | seekingalpha.com10 Solid Reasons To Buy Hims & Hers StockMay 9, 2024 | finance.yahoo.comResults: Hims & Hers Health, Inc. Beat Earnings Expectations And Analysts Now Have New ForecastsMay 8, 2024 | seekingalpha.comHims & Hers: Strong Operating Leverage And Profitability InflectionMay 8, 2024 | marketbeat.comAnalysts Offer Predictions for Hims & Hers Health, Inc.'s Q2 2024 Earnings (NYSE:HIMS)Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) - Seaport Res Ptn lifted their Q2 2024 earnings per share estimates for shares of Hims & Hers Health in a report issued on Monday, May 6th. Seaport Res Ptn analyst A. Kessler now anticipates that the company will post earnings per share of $0.05 Get Hims & Hers Health News Delivered to You Automatically Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter. Email Address Everybody laughed when he recommended Netflix (Ad)"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. HIMS Media Mentions By Week HIMS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HIMS News Sentiment▼0.520.44▲Average Medical News Sentiment HIMS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HIMS Articles This Week▼397▲HIMS Articles Average Week Get Hims & Hers Health News Delivered to You Automatically Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TDOC News Today OLK News Today QDEL News Today LTH News Today IOVA News Today CORT News Today ENOV News Today GH News Today TNDM News Today ARWR News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:HIMS) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersBiden Nomination CANCELED?The Freeport SocietyWrite this ticker symbol down…StocksToTradeShocking $16T Elon Musk Crypto LeakCrypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsWarren Buffett's "mystery stock"Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
